secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aditxt, Inc. (ADTX)
CIK:        0001726711
Form:       8-K
Filed at:   2023-12-21T23:59:59+00:00
Accession:  0001213900-23-097705
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aditxt enters asset purchase agreement to acquire MDNA's early cancer detection platform
--------------------------------------------------------------------------------

- Pearsanta to acquire MDNA's early cancer detection IP for $1M cash + 50K Aditxt shares + warrants + Pearsanta preferred valued up to $25M.
- Closing requires Aditxt/Pearsanta to raise at least $10M in debt or equity financing.
- MDNA can terminate if Aditxt fails to pay $500K upfront working capital by December 31, 2023.
- Pearsanta preferred shares designed to provide as-converted value of $25M; additional shares if shortfall.
- Warrants for 50K Aditxt shares exercisable at closing price for 5 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1726711/000121390023097705/0001213900-23-097705-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1726711/000121390023097705/ea190477-8k_aditxtinc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-097705

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer